Sciencare Medical Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 127

Employees

  • Latest Deal Type
  • IPO
  • (Cancelled)

  • Investors
  • 10

Sciencare Medical General Information

Description

Developer of addiction treatment drugs intended to prevent opioid drug users from relapse. The company focuses on the core technology of sustained and controlled drug addiction treatment, and the naltrexone sustained-release agent developed has completed phase II clinical trials. Naltrexone is the only opioid anti-relapse drug recommended by WHO. The company has developed naltrexone sustained-release agent through subcutaneous implantation to release the drug slowly and evenly, effectively solving the industry's pain points of relapse of opioids.

Contact Information

Website
www.sciencare.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building C- 2101, Changfang Lighting Industrial Factory
  • Zhukeng Community, Longtian Street
  • Shenzhen, Guangdong
  • China
+86 0755
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
LOHAS & Wellness
Corporate Office
  • Building C- 2101, Changfang Lighting Industrial Factory
  • Zhukeng Community, Longtian Street
  • Shenzhen, Guangdong
  • China
+86 0755

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sciencare Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. IPO 24-Sep-2024 Cancelled Clinical Trials - Phase 3
7. Early Stage VC 21-Jun-2022 Completed Clinical Trials - Phase 3
6. Early Stage VC (Series B) 25-Aug-2021 Completed Clinical Trials - Phase 3
5. Secondary Transaction - Private 24-Dec-2020 Completed Clinical Trials - General
4. Early Stage VC 10-Sep-2020 Completed Clinical Trials - General
3. Early Stage VC 08-Apr-2020 Completed Clinical Trials - General
2. Early Stage VC 20-Nov-2019 $2.84M $2.84M Completed Startup
1. Early Stage VC 08-Jan-2018 Completed Startup
To view Sciencare Medical’s complete valuation and funding history, request access »

Sciencare Medical Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary 2,108,728 $3.19 $3.19 1x $3.19 7.03%
Ordinary 1,089,015 $2.74 $2.74 1x $2.74 3.63%
To view Sciencare Medical’s complete cap table history, request access »

Sciencare Medical Patents

  • 11

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Sciencare Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4527372-A1 Preparation method for long-acting sustained release implant Pending 15-Aug-2022
EP-4527372-A4 Preparation method for long-acting sustained release implant Pending 15-Aug-2022
WO-2024037535-A1 Preparation method for long-acting sustained release implant Inactive 15-Aug-2022
US-20260007593-A1 Preparation method of long-acting sustained and controlled release implant Pending 15-Aug-2022
WO-2024037536-A1 Sustained-release formulation containing varenicline and preparation method therefor Inactive 15-Aug-2022 A61K31/55
To view Sciencare Medical’s complete patent history, request access »

Sciencare Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sciencare Medical Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Tibet Rongrui Investment PE/Buyout Minority
CAS Investment Management Growth/Expansion Minority
Huajin Venture Capital Corporate Venture Capital Minority
Xiangjiang Liyuan Investment Growth/Expansion Minority
People.cn Ventures Corporation Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Sciencare Medical FAQs

  • When was Sciencare Medical founded?

    Sciencare Medical was founded in 2017.

  • Where is Sciencare Medical headquartered?

    Sciencare Medical is headquartered in Shenzhen, China.

  • What is the size of Sciencare Medical?

    Sciencare Medical has 127 total employees.

  • What industry is Sciencare Medical in?

    Sciencare Medical’s primary industry is Drug Discovery.

  • Is Sciencare Medical a private or public company?

    Sciencare Medical is a Private company.

  • What is Sciencare Medical’s current revenue?

    The current revenue for Sciencare Medical is .

  • How much funding has Sciencare Medical raised over time?

    Sciencare Medical has raised $85.9M.

  • Who are Sciencare Medical’s investors?

    Tibet Rongrui Investment, CAS Investment Management, Huajin Venture Capital, Xiangjiang Liyuan Investment, and People.cn Ventures are 5 of 10 investors who have invested in Sciencare Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process